| Literature DB >> 20503038 |
S W Y Tsang1, C H Bow, E Y W Chu, S C Yeung, C C Soong, A W C Kung.
Abstract
UNLABELLED: This study evaluated the characteristics of patients with vertebral fractures and examined the discriminative ability of clinical risk factors. The findings provide further insights into possible development of a simple, cost-effective scheme for fracture risk assessment using clinical risk factors to identify high-risk patients for further evaluation.Entities:
Mesh:
Year: 2010 PMID: 20503038 PMCID: PMC3020297 DOI: 10.1007/s00198-010-1260-z
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
Baseline characteristics of postmenopausal women with and without prevalent vertebral fracture (n = 1,372)
| No vertebral fracture ( | Vertebral fracture ( | |
|---|---|---|
| Age (mean ± SD) (year) | 59.8 ± 7.7 | 66 ± 10.1* |
| Weight (mean ± SD) (kg) | 55.3 ± 9.91 | 55.4 ± 10.0 |
| Height (mean ± SD) (cm) | 153.6 ± 0.06 | 151.2 ± 0.06** |
| Body mass index (mean ± SD) (kg/m2) | 23.1 ± 3.4 | 24.2 ± 3.9* |
| Age at menarche (mean ± SD) (year) | 13.9 ± 2.0 | 14.7 ± 2.2* |
| Age at menopause (mean ± SD) (year) | 49.5 ± 3.9 | 49.7 ± 4.3 |
| Years since menopause (mean ± SD) (year) | 11.1 ± 8.3 | 17.3 ± 10.4** |
| Dietary calcium intake (mean ± SD) (mg/day) | 681.1 ± 273.6 | 652.7 ± 279.5 |
| Dietary isoflavone intake (mean ± SD) (mg/day) | 25.4 ± 28.3 | 21.4 ± 25.3 |
| Age ≥ 65 years | 283 (26.4%) | 163 (54.5%)** |
| BMI < 19 | 26 (2.4%) | 11 (3.7%) |
| Age at menarche > 14 years | 549 (51.2%) | 196 (65.6%)** |
| Years since menopause >5 years | 673 (62.7%) | 234 (78.3%)** |
| Dietary calcium intake <400 mg/day | 159 (14.8%) | 53 (17.7%) |
| Dietary isoflavone intake <9.6 mg/day | 350 (32.7%) | 107 (35.8%) |
| Bilateral-oophorectomy | 64 (6.0%) | 17 (5.7%) |
| Current smoker or drinker | 46 (4.3%) | 22 (7.4%)* |
| Steroid use | 5 (0.5%) | 1 (0.3%) |
| Previous history of taking contraceptive pills | 407 (37.9%) | 84 (28.1%)* |
| Previous history of low back pain | 568 (52.9%) | 175 (58.7%) |
| Previous history of thyroid disease | 54 (5.0%) | 16 (5.4%) |
| Previous history of fracture after age of 45 yearsa | 91 (8.5%) | 79 (26.4%)** |
| Previous history of clinical spine fracture (self-reported) | 0 (0%) | 32 (10.7%)** |
| History of maternal fracture after age of 45 years | 183 (17.1%) | 29 (9.7%)** |
| ≥1 fall in 12 months | 168 (15.7%) | 64 (21.4%)** |
| Walking <30 min/day | 138 (12.9%) | 43 (14.4%) |
| Any one site BMD T-score ≤ −2.5 | 244 (22.7%) | 130 (43.6%)** |
*p < 0.05; **p < 0.001
aExcluding clinical spine fracture
Comparison of bone mineral density (BMD) between postmenopausal women with and without prevalent vertebral fractures
| No vertebral fracture ( | Vertebral fracture ( | |
|---|---|---|
| Lumbar spine (L1–L4) T-scorea | ||
| Mean T-score (95% CI) | −1.34 (−1.40, −1.27) | −1.75 (−1.89, −1.61) ** |
| T-score >−1 | 37.0%* | 28.2% * |
| T-score <−1 and >−2.5 | 44.1%* | 40.3%* |
| T-score ≤−2.5 | 17.1%* | 31.2% * |
| Total hip T-scorea | ||
| Mean T-score (95% CI) | −1.05 (−1.12, −0.99) | −1.65 (−1.79, −1.52) * |
| T-score >−1 | 47.3%* | 32.4% * |
| T-score <−1 and >−2.5 | 38.8%* | 38.5%* |
| T-score ≤−2.5 | 11.2%* | 28.5% * |
| Femoral neck T-scorea | ||
| Mean T-score (95% CI) | −1.24 (−1.29, −1.18) | −1.75 (−1.87, −1.64) ** |
| T-score >−1 | 39.5%* | 24.7% * |
| T-score <−1 and >−2.5 | 45.8%* | 46.5%* |
| T-score ≤−2.5 | 13.4%* | 27.8% * |
t test for comparison of mean T-score and ANOVA test for category of T-score
*p < 0.05; **p < 0.001
aLocal Southern Chinese normative database was used for calculation of T-scores
Risk factors for prevalent vertebral fractures based on logistic regression model
| Odds ratio | 95% CI |
| |
|---|---|---|---|
| Age (every 5 years increase) | 1.60 | 1.46–1.76 | <0.0001 |
| Height | 0.86 | 0.83–0.97 | <0.0001 |
| Weight | 0.97 | 0.95–0.98 | 0.001 |
| Body mass index (treat as continuous variable) | 1.05 | 1.01–1.09 | 0.006 |
| Menarche age | 1.20 | 1.12–1.30 | <0.0001 |
| Age at menopause | 1.00 | 0.96–1.04 | 0.94 |
| Years since menopause | 1.08 | 1.06–1.10 | <0.0001 |
| Current smoker/drinker | 1.99 | 1.19–3.33 | 0.008 |
| Dietary calcium intake <400 mg/day | 1.46 | 1.03–2.06 | 0.03 |
| Dietary isoflavone intake <9.6 mg/day | 1.15 | 0.88–1.50 | 0.30 |
| Steroid use | 1.41 | 0.16–12.1 | 0.75 |
| Previous history of taking contraceptive pills | 0.44 | 0.30–0.65 | <0.0001 |
| Previous history of thyroid disease | 1.49 | 0.78–2.85 | 0.21 |
| Previous history of fracture after age of 45 yearsa | 3.80 | 2.77–5.41 | <0.0001 |
| History of maternal fracture after age of 45 years | 1.23 | 0.52–1.88 | 0.46 |
| 1 or more falls in 12 months | 3.27 | 2.29–4.65 | <0.0001 |
aExcluded clinical vertebral fracture
Prevalence of one or more vertebral fracture according to the number of clinical risk factors and femoral neck BMD T-score
| Prevalence of vertebral fracture | Odds ratio (95% CI) |
| |
|---|---|---|---|
| Number (%) ( | |||
| Number of clinical risk factors | |||
| 0–1 | 70/571 (12.3) | Reference group | |
| 2–3 | 133/596 (22.3) | 1.13 (0.77, 1.65) | 0.54 |
| ≥4 | 96/205 (46.8) | 2.26 (1.36, 3.73) | <0.05 |
| No. of clinical risk factors + femoral neck BMD T-score | |||
| 0–1 Clinical risk factor + BMD T-score ≥−2.5 | 69/553 (12.5) | Reference group | |
| 0–1 Clinical risk factor + BMD T-score <−2.5 | 1/18 (5.6) | 0.37 (0.05, 2.80) | 0.33 |
| 2–3 Clinical risk factors + BMD T-score <−2.5 | 25/96 (26.0) | 1.00 (0.54, 1.87) | 0.99 |
| ≥4 Clinical risk factors + BMD T-score <−2.5 | 56/102 (54.9) | 2.64 (1.42, 4.91) | <0.05 |
Fig. 1Prevalence (%) of vertebral fractures by age and the number of risk factors in Hong Kong Southern Chinese postmenopausal women. The number of Southern Chinese women in each group was as follows: <60, n = 665; 60–69, n = 459; 70–79, n = 204; 80+, n = 44. Risk factors included BMI <19 kg/m2, menarche age >14 years, years since menopause >5 years, daily calcium intake <400 mg/day, current smoker or drinker, history of fall, and fracture history (excluded clinical vertebral fracture)
OR (95% CI) for prevalent vertebral fracture for 1 SD decrease in BMD, BMC, or BMAD: age, age and body weight, and multivariable-adjusted models in 1,372 Southern Chinese postmenopausal women
| Southern Chinese | ||
|---|---|---|
| OR (95% CI) | AUC | |
| Lumbar spine BMD | ||
| Age-adjusted | 1.51 (1.19, 1.90) | 0.627 |
| Age and body weight | 1.64 (1.26, 2.15) | 0.635 |
| Multivariatea | 1.46 (1.11, 1.93) | 0.700 |
| Lumbar spine BMC | ||
| Age-adjusted | 1.49 (1.17, 1.90) | 0.631 |
| Age and body weight | 1.58 (1.21, 2.05) | 0.636 |
| Multivariatea | 1.40 (1.06, 1.86) | 0.699 |
| Lumbar spine BMAD | ||
| Age-adjusted | 1.39 (1.11, 1.75) | 0.617 |
| Age and body weight | 1.45 (1.14, 1.86) | 0.623 |
| Multivariatea | 1.39 (1.06, 1.81) | 0.697 |
| Femoral neck BMD | ||
| Age-adjusted | 1.52 (1.18, 1.98) | 0.612 |
| Age and body weight | 1.69 (1.26, 2.27) | 0.628 |
| Multivariatea | 1.43 (1.05, 1.95) | 0.692 |
| Femoral neck BMC | ||
| Age adjusted | 1.51 (1.17, 1.94) | 0.612 |
| Age and body weight | 1.72 (1.28, 2.33) | 0.623 |
| Multivariatea | 1.42 (1.04, 1.96) | 0.698 |
| Femoral neck BMAD | ||
| Age-adjusted | 1.38 (1.07, 1.77) | 0.597 |
| Age and body weight | 1.41 (1.08, 1.85) | 0.603 |
| Multivariatea | 1.29 (0.97, 1.70) | 0.683 |
aHong Kong Southern Chinese aged 45 and above: multivariable model includes adjustment for age, BMI, menarche age, years since menopause, smoking or drinking, calcium intake, fracture history, fall in the last 12 months